AVRIO Pharmacy Funding: How Much Did They Raise & Key Investors

How Much Did AVRIO Pharmacy Raise?
Funding & Key Investors

AVRIO Pharmacy has solidified its market position through a series of significant capital injections, culminating in a total funding accumulation of $548K. The most recent strategic investment, totaling $398K, underscores the firm's aggressive expansion trajectory within the specialized pharmaceutical sector. By leveraging debt-based financing, the Scottsdale-based entity has successfully scaled its operational infrastructure to meet the rising demand for bespoke medical solutions.

This financial milestone reflects a robust confidence from institutional lenders in the company's ability to navigate the complex regulatory landscape of compounded medications. As the firm continues to integrate advanced formulation technologies, this influx of capital serves as a critical catalyst for enhancing its service delivery model across both human and veterinary health verticals.

What is AVRIO Pharmacy?

AVRIO Pharmacy

Retail

Drug Stores & Pharmacies

AVRIO Pharmacy operates as a specialized provider of high-quality compounded medications, distinguishing itself from traditional retail pharmacy models through its focus on tailored therapeutic solutions. Based in Scottsdale, Arizona, the company addresses critical gaps in the healthcare market by offering customized formulations for pain management, pediatric care, and gender-specific health needs. Their operational model is built upon a decade of clinical expertise, positioning them as a vital partner for healthcare providers seeking non-standardized treatment options that are unavailable through conventional pharmaceutical channels.

How much funding has AVRIO Pharmacy raised?

AVRIO Pharmacy has raised a total of $548K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$398K

Debt (2020): $150K with participation from PPP

Debt (2021): $398K led by PPP

Key Investors in AVRIO Pharmacy

PPP

Public-Private Partnership

What's next for AVRIO Pharmacy?

With the recent infusion of capital, AVRIO Pharmacy is poised to accelerate its strategic growth initiatives, likely focusing on the expansion of its compounding laboratory capabilities and the optimization of its supply chain logistics. The company's trajectory suggests a shift toward broader market penetration, potentially leveraging its established reputation in veterinary and human health to capture a larger share of the personalized medicine market. Future developments will likely center on technological integration to streamline patient-provider communication and the scaling of its proprietary formulation processes to maintain high-quality standards during rapid growth phases.

See full AVRIO Pharmacy company page

See More Financial Insights